Search company, investor...
Search
Miramar Labs company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

miramarlabs.com

Founded Year

2006

Stage

Acquired | Acquired

Total Raised

$101.14M

Valuation

$0000 

About Miramar Labs

Miramar Labs is a clinical-stage medical device company that has developed miraWave, a technology platform using microwave energy for treatment in medical areas such as dermatology, oncology, cardiology and urology.

Miramar Labs Headquarters Location

2790 Walsh Avenue

Santa Clara, California, 95051,

United States

408-940-8700

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Miramar Labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Miramar Labs is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

11,575 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health IT

7,901 items

Miramar Labs Patents

Miramar Labs has filed 20 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/24/2014

9/22/2020

Hair removal, H1 receptor antagonists, Human hair, Antiandrogens, Calcium channel blockers

Grant

Application Date

7/24/2014

Grant Date

9/22/2020

Title

Related Topics

Hair removal, H1 receptor antagonists, Human hair, Antiandrogens, Calcium channel blockers

Status

Grant

Latest Miramar Labs News

Aziyo Biologics Announces New Appointments to Board of Directors

Sep 21, 2020

| Source: Aziyo Biologics SILVER SPRING, Md., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today that Maybelle Jordan, Vice President of Business Development of Biomerix Corporation, and Brigid Makes, former Senior Vice President and Chief Financial Officer of Miramar Labs, have joined its board of directors. Maybelle Jordan has served as Vice President of Business Development of Biomerix Corporation, a biomaterials company focused on scaffold technology in the medical technology industry, since 2011, and as Chief Operating Officer for Biomerix from 2003 to 2011. She also co-founded and served as President and CEO of MTrap Inc., a clinical-stage biomaterials company developing a cancer therapeutic device for treatment of advanced ovarian cancer, from 2015 to 2019. Ms. Jordan holds an M.B.A. from Harvard University and a B.S. Brigid A. Makes has served as an independent consultant for medical device and healthcare companies since July 2017, specifically advising on finance, accounting and funding responsibilities. From September 2011 to July 2017, Ms. Makes served as Senior Vice President and Chief Financial Officer of Miramar Labs, Inc., a biotechnology company focused on aesthetics and dermatology. Prior to that, she served as Senior Vice President and Chief Financial Officer of AGA Medical Corp, a medical device company developing interventional devices for the minimally invasive treatment of structural heart defects and peripheral vascular disorders. Prior to joining AGA, Ms. Makes held various positions at Nektar Therapeutics Inc. from 1999 to 2006, including serving as Chief Financial Officer. Since December 2019, she has also served as a member of the board of directors of Mind Medicine (MindMed) Inc. a publicly-traded neuro-pharmaceutical company. Ms. Makes holds an M.B.A. from Bentley University and a Bachelor of Commerce degree in Finance & International Business from McGill University. “I couldn’t be more excited to welcome Maybelle and Brigid, women of significant accomplishments, to our board of directors,” said Ron Lloyd, President and Chief Executive Officer, Aziyo Biologics. “Their expertise across biologics and medical devices will complement the broad range of experience of our Board of Directors. We are confident that they will provide valuable perspectives as we continue to expand our portfolio of products, build deeper relationships with customers, and execute on our mission of improving patient outcomes in patients facing implantable device-related complications.” About Aziyo Biologics Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo. c om . Contacts:

  • When was Miramar Labs founded?

    Miramar Labs was founded in 2006.

  • Where is Miramar Labs's headquarters?

    Miramar Labs's headquarters is located at 2790 Walsh Avenue, Santa Clara.

  • What is Miramar Labs's latest funding round?

    Miramar Labs's latest funding round is Acquired.

  • How much did Miramar Labs raise?

    Miramar Labs raised a total of $101.14M.

  • Who are the investors of Miramar Labs?

    Investors of Miramar Labs include Sientra, Miramar Technologies, Morgenthaler Ventures, Domain Associates, Cross Creek and 5 more.

  • Who are Miramar Labs's competitors?

    Competitors of Miramar Labs include Suneva Medical, Lumenis, Cagenix, Direct Flow Medical, Shaser and 12 more.

You May Also Like

N
NDO Surgical

Medical devices for the treatment of severe gastrointestinal disorders

C
Carapacics

Carapacics offers biomedical devices

C
C2C

C2C is a medical device company developing a portfolio of medical devices.

G
Gaymar Industries

Gaymar Industries is a manufacturer of specialty medical devices

P
Pavad Medical

Pavad develops medical devices for the treatment of sleep apnea.

D
Direct Flow Medical

Direct Flow Medical is focused on developing novel transcatheter heart valve technologies that improve patient outcomes while reducing patient complications. The company is exploring application of its proprietary technology beyond the aortic valve, to the mitral valve and other valve anatomy. Headquartered in Santa Rosa, California, the company also has technology and manufacturing facilities in Lake Forest, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.